NCT00113373 2019-07-24Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal CancerNational Cancer Institute (NCI)Phase 2 Completed28 enrolled 11 charts
NCT00436644 2014-04-16Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinMayo ClinicPhase 2 Completed18 enrolled 10 charts